Ain Shams Medical Research Center (MASRI) strives to be a leading center in scientific research in Egypt and the entire region, as it contains 6 departments for scientific research, In cooperation with the Faculties of Pharmacy, Dentistry, Nursing, as well as the corresponding Faculties of Medicine at the regional level, in addition to cooperation with the Universities of Zewail and the Nile.
The center aims to develop the medical and biomedical research and translating it into benefits for society, for a better health future through four main objectives: promoting excellence, developing talented researchers, influencing research and engaging patients, the public and professionals in cooperation with biomedical and health researchers and liaising with decision-makers, as well as providing opportunities Multidisciplinary across academia, industry and health care in its various forms within the biomedical and health research community.
The center contains 6 departments for pre-clinical research, genome research, and stem cell research, as well as an accredited center for clinical research, a unit for treatment and research of hepatitis and a unit for bioinformatics. In addition to the establishment of a cancer biobank for the first time, which is the largest in the Arab region, and contains tissues and organic samples, and the associated clinical characteristics for about 28 thousand patients. Through the center, researchers aspire to know the genetic characteristics of Egyptian cancer patients, which in turn will be reflected in drug discovery and careful selection of drugs in the so-called personalized medicine.
It is noteworthy that the center is closely related to the Drug Discovery Center at the College of Pharmacy, with the aim of discovering new patterns of medicine in various branches, especially liver tumors, adding that the center has several partnerships with Egyptian and international research centers such as Zewail University, the National Research Center, and Fudan University of China, which are ranked at the center 40 In the world in cancer treatment, the French University of Montpellier. He pointed out that the total income of the center from joint research amounted to about 200 thousand dollars with some American research bodies.
The Board of Directors consists of several Egyptian and foreign scientists, including: Professor Ahmed Kasib, Head of the Liver Tumor Unit at the MD Anderson Institute in the United States of America, and Dr. Pascal Pujol, Head of the Genetics Unit at the University of Montpellier, France, Mr. Tarek Al-Kholy, Chairman of the Board of Directors of Saib Bank.